JBT Marel Corporation (JBTM)
NYSEIndustrialsIndustrial - MachinerySnapshot 2026-09-04
$117.72+0.07%
Close 2026-09-04 · 1-day change
NYSEIndustrialsIndustrial - MachinerySnapshot 2026-09-04
Broken: Recent financial performance freshly dropped to the bottom half of its industry.
JBT Marel grows revenue about 6% a year, meeting its 5-7% target. Profit margins remain stable with EPS guidance near $4.92 for 2026. The company is buying back $200 million of stock, showing strong capital allocation. Synergy cost savings of $60 million support profitability.
Revenue growth could slow below 5%, hurting earnings. Cost savings may fall short of $60 million. The company is loss-making, which risks cash flow and valuation.
The price is about 22% below our fair value near $183. Analysts expect roughly 6% revenue growth, which aligns with management guidance. Our view is consistent with these expectations.
Breaks if: Share repurchase program is canceled or materially reduced
Breaks if: Synergy cost savings fall below $50 million in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround play, as JBTM is currently navigating challenges in execution and sector performance. The thesis is in a weakened state due to recent earnings misses and a decline in financial performance relative to peers.
The market appears to have priced in a level of fragility, as JBTM is seen as expensive compared to its peers. There is a notable expectations gap, indicating that the current valuation reflects a cautious outlook on future performance.
Management is focused on achieving synergy cost savings and revenue growth targets, with some progress noted. However, the company remains loss-making, and near-term risks are moderate, with a low probability of missing earnings expectations.
The long-term thesis hinges on management's ability to execute on cost savings and revenue growth while monitoring the performance of sector bellwethers. Any cuts to guidance or negative trends in the sector could significantly impact JBTM's outlook.
The most important moves since the prior daily snapshot.
Yes, our read has weakened. The reason to own JBTM has diminished recently. Recent financial performance dropped from the robust half to the weak half of its sector. Additionally, the company missed earnings expectations in its latest report.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Continue executing integration and cost synergy initiatives to realize $60 million in annualized cost savings in 2026.
Stated as a priority in 3 of last 3 quarters. The Company realized $43 million in synergy savings in 2025 and targets $60 million in 2026. Management reiterated the $60 million synergy savings target consistently, indicating ongoing execution with limited progress data but persistent focus.
“We continue to execute on our integration and cost synergy initiatives, which we expect will enable $60 million of in-year realized savings for 2026.”
“The Company remains on-track to achieve an estimated $60 million in realized synergy cost savings for the full year 2026.”
“For the full year 2026, JBT Marel anticipates approximately $60 million in year-over-year synergy savings.”
Breaks if: EPS guidance midpoint falls below $4.7 in FY26
Breaks if: YoY revenue growth falls below 5% in FY26
In the next 1 to 3 years, JBTM's performance will largely depend on its execution and external sector conditions. Not investment advice.